Can atherogenic lipoproteins impair endothelial function and stress the renal microcirculation?

Atherogenic ApoB-containing lipoproteins have a credible renal vascular relevance, but the complete pathway from lipoprotein exposure to progressive renal microcirculatory injury in humans remains inferential rather than directly established.

Endothelial and renal vascular effects

• Oxidized LDL and oxidized lipoprotein(a) [Lp(a)] increased superoxide/free-radical generation in renal vascular and renal-cell experiments. This oxidative stress can reduce nitric-oxide bioavailability and impair normal endothelial vasodilation.
• Oxidized Lp(a) impaired endothelium-dependent renal-artery dilation, while retention and oxidation of ApoB-containing particles activate endothelial inflammatory and adhesion pathways.
• Human evidence is directionally consistent: in a small cross-sectional study, smaller LDL particles were associated with a 39% lower acetylcholine-stimulated forearm blood-flow response. This supports an association with endothelial dysfunction but does not establish cause, timing, or renal specificity.

Mechanistic implications

• Superoxide-mediated nitric-oxide depletion provides a biologically coherent mechanism linking oxidized atherogenic lipoproteins to vascular dysfunction, impaired autoregulatory vasodilation, and susceptibility to ischemic stress in the renal circulation.
• In renal-artery experiments, oxidized LDL increased free-radical generation and worsened ischemia–reperfusion oxidative stress; HDL pretreatment attenuated these effects and preserved nitric-oxide activity.
• Oxidized LDL also stimulated renin release from juxtaglomerular cells, identifying a potential vasoactive pathway through which oxidative lipoprotein injury could influence intrarenal hemodynamics.

Clinical interpretation

• In a large CKD cohort, Lp(a) ≥30 mg/dL was associated with CKD progression (adjusted HR 1.13, 95% CI 1.06–1.21). This is compatible with clinical relevance, although it cannot establish that microvascular injury mediates the association.

Bottom line

• Atherogenic lipoproteins clearly can impair endothelial biology; their contribution to small-vessel injury and chronic renal microcirculatory stress is biologically plausible, but not yet directly demonstrated longitudinally in humans.